Modulation of immune tolerance via siglec-sialic acid interactions

J Lübbers, E Rodríguez, Y Van Kooyk - Frontiers in immunology, 2018 - frontiersin.org
One of the key features of the immune system is its extraordinary capacity to discriminate
between self and non-self and to respond accordingly. Several molecular interactions allow …

Sialic acid mimetics to target the sialic acid–Siglec axis

C Büll, T Heise, GJ Adema, TJ Boltje - Trends in biochemical sciences, 2016 - cell.com
Sialic acid sugars are vital regulators of the immune system through binding to
immunosuppressive sialic acid-binding immunoglobulin-like lectin (Siglec) receptors on …

Current status on therapeutic molecules targeting Siglec receptors

MP Lenza, U Atxabal, I Oyenarte, J Jiménez-Barbero… - Cells, 2020 - mdpi.com
The sialic acid-binding immunoglobulin-type of lectins (Siglecs) are receptors that recognize
sialic acid-containing glycans. In the majority of the cases, Siglecs are expressed on …

Synthesis of N-Glycolylneuraminic Acid (Neu5Gc) and Its Glycosides

AS Kooner, H Yu, X Chen - Frontiers in immunology, 2019 - frontiersin.org
Sialic acids constitute a family of negatively charged structurally diverse monosaccharides
that are commonly presented on the termini of glycans in higher animals and some …

Therapeutic targeting of siglecs using antibody-and glycan-based approaches

T Angata, CM Nycholat, MS Macauley - Trends in pharmacological …, 2015 - cell.com
The sialic acid-binding immunoglobulin-like lectins (Siglecs) are a family of
immunomodulatory receptors whose functions are regulated by their glycan ligands. Siglecs …

Disubstituted sialic acid ligands targeting siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas

CD Rillahan, MS Macauley, E Schwartz, Y He… - Chemical …, 2014 - pubs.rsc.org
The siglec family of sialic acid-binding proteins are endocytic immune cell receptors that are
recognized as potential targets for cell directed therapies. CD33 and CD22 are prototypical …

A sulfonamide sialoside analogue for targeting Siglec-8 and-F on immune cells

CM Nycholat, S Duan, E Knuplez, C Worth… - Journal of the …, 2019 - ACS Publications
The Siglec family of cell surface receptors have emerged as attractive targets for cell-
directed therapies due to their restricted expression on immune cells, endocytic properties …

CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance

L Nitschke - Glycobiology, 2014 - academic.oup.com
CD22 and Siglec-G are two B-cell expressed members of the Siglec (sialic acid-binding
immunoglobulin (Ig)-like lectin) family and are potent inhibitors of B-cell signaling. Genetic …

Steering Siglec–sialic acid interactions on living cells using bioorthogonal chemistry

C Büll, T Heise, N van Hilten… - Angewandte Chemie …, 2017 - Wiley Online Library
Sialic acid sugars that terminate cell‐surface glycans form the ligands for the sialic acid
binding immunoglobulin‐like lectin (Siglec) family, which are immunomodulatory receptors …

Tetra‐and Hexavalent Siglec‐8 Ligands Modulate Immune Cell Activation

G Conti, A Bärenwaldt, S Rabbani… - Angewandte …, 2023 - Wiley Online Library
Carbohydrate‐binding proteins are generally characterized by poor affinities for their natural
glycan ligands, predominantly due to the shallow and solvent‐exposed binding sites. To …